Pharmacological Progresses of Puerarin in the Prevention and Treatment of Atherosclerosis

被引：0
作者：
Jia, Liyi [1 ]
Xing, Lu. [2 ]
Li, Pengquan [2 ]
Chu, Haiqing [2 ]
Zhou, Xin [2 ]
Qin, Wei [2 ]
He, Chunxia [2 ]
Li, Huijin [2 ]
Zhao, Dong [2 ]
Zhang, Juan [1 ]
Cao, Huiling [2 ]
机构：
[1] Shaanxi Univ Chinese Med, Coll Pharm, Xianyang 712046, Shaanxi, Peoples R China
[2] Xian Med Univ, Coll Pharm, Xian Key Lab Basic & Translat Cardiovasc Metab Dis, Xian 710021, Shaanxi, Peoples R China
来源：
INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES | 2023年 / 85卷 / 04期
基金：
芬兰科学院;
关键词：
Puerarin; atherosclerosis; hyperglycemic; anti-inflammatory; pharmacological activity; RADIX-PUERARIAE; HYPERGLYCEMIA; OPTIMIZATION; DAIDZEIN; PATHWAY;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Atherosclerosis is an independent risk factor for cardiovascular diseases, which is related to dyslipidemia, endothelial injury, inflammation, thrombosis, dysfunction of vascular smooth muscle cells and macrophages, etc. Puerarin, a natural monomer from Chinese herb Pueraria lobata, presents multiple cardiovascular protective activities. The paper firstly reviewed the risk factors and drug of atherosclerosis. And then, extraction and synthesis of puerarin were summarized. Especially, it focused on the latest advances in anti-atherosclerosis activities of puerarin from six aspects including lipid-regulating, hyperglycemic, antiinflammatory, inhibiting thrombosis, promoting microcirculation, improving functions of vascular smooth muscle cells and macrophages. Some novel puerarin derivatives also exhibited favorable anti-atherosclerosis activity. The review would provide new molecular skeletons and lead compounds for anti-atherosclerosis new drug development based on puerarin.
引用
收藏
页码：884 / 894
页数：11
相关论文
共 50 条
  • [41] Statines in prevention and treatment of atherosclerosis connected diseases: efficiency and safety
    Karpov, Y. A.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2005, 1 (02) : 48 - 53
  • [42] Immuno-modulatory role of baicalin in atherosclerosis prevention and treatment: current scenario and future directions
    Wang, Li
    Huang, Shenyi
    Liang, Xiaolun
    Zhou, Junliang
    Han, Yifan
    He, Jiangshan
    Xu, Danping
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [43] Puerarin inhibits the inflammatory response in atherosclerosis via modulation of the NF-κB pathway in a rabbit model
    Ji, Ling
    Du, Qiang
    Li, YunTao
    Hu, Wenzhi
    PHARMACOLOGICAL REPORTS, 2016, 68 (05) : 1054 - 1059
  • [44] Puerarin: A Review on the Pharmacological Activity, Chemical Properties and Pharmacokinetics of Main Isoflavonoid
    Ojo, Oluwafemi Adeleke
    Ojo, Adebola Busola
    Nwonuma, Charles Obiora
    Awakan, Oluwakemi Josephine
    Maimako, Rotdelmwa Filibus
    Afolabi, Boluwatife Lawrence
    Taiwo, Odunayo Anthonia
    NATURAL PRODUCTS JOURNAL, 2022, 12 (01)
  • [45] THE PREVENTION OF ATHEROSCLEROSIS WITH ANTIOXIDANTS
    HARRIS, WS
    CLINICAL CARDIOLOGY, 1992, 15 (09) : 636 - 640
  • [46] Targeting residual inflammatory risk: The next frontier for atherosclerosis treatment and prevention
    Ridker, Paul M.
    VASCULAR PHARMACOLOGY, 2023, 153
  • [47] Quantification of puerarin and daidzein and in vitro pharmacological evaluation of Pueraria tuberosa (Willd.) DC.: An ethnopharmacological approach
    Sarmah, Bikash
    Shukla, Pushpendra Kumar
    Sarma, Manoj Kumar
    Sharma, Rolee
    ANNALS OF PHYTOMEDICINE-AN INTERNATIONAL JOURNAL, 2022, 11 (01): : 505 - 516
  • [48] EFFICIENCY OF THE DIET THERAPY IN THE PREVENTION AND TREATMENT IN THE ATHEROSCLEROSIS IN OBESE CHILDREN AND ADOLESCENTS
    Costa, Carla Fernandes
    Batista, Carolina de Paula
    Vieira Verissimo Aguiar, Shirlei Estela
    Navarro, Antonio Coppi
    RBONE-REVISTA BRASILEIRA DE OBESIDADE NUTRICAO E EMAGRECIMENTO, 2008, 2 (08): : 168 - 181
  • [49] Elucidation of active ingredients and mechanism of action of hawthorn in the prevention and treatment of atherosclerosis
    Li, Huan
    Gao, Lei
    Shao, Huili
    Li, Bingqian
    Zhang, Chao
    Sheng, Huagang
    Zhu, Liqiao
    JOURNAL OF FOOD BIOCHEMISTRY, 2022, 46 (12)
  • [50] Immune-mediated mechanisms in atherosclerosis: Prevention and treatment of clinical manifestations
    Niessner, A.
    Goronzy, J. J.
    Weyand, C. M.
    CURRENT PHARMACEUTICAL DESIGN, 2007, 13 (36) : 3701 - 3710
12345